GHP Investment Advisors Inc. raised its stake in Innophos Holdings, Inc. (NASDAQ:IPHS) by 32.0% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 7,392 shares of the specialty chemicals company’s stock after buying an additional 1,793 shares during the period. GHP Investment Advisors Inc.’s holdings in Innophos Holdings were worth $364,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the business. Prudential Financial Inc. increased its holdings in Innophos Holdings by 28.9% in the third quarter. Prudential Financial Inc. now owns 221,651 shares of the specialty chemicals company’s stock valued at $10,903,000 after buying an additional 49,630 shares in the last quarter. IndexIQ Advisors LLC increased its holdings in Innophos Holdings by 83.0% in the third quarter. IndexIQ Advisors LLC now owns 16,058 shares of the specialty chemicals company’s stock valued at $790,000 after buying an additional 7,281 shares in the last quarter. American Century Companies Inc. increased its holdings in Innophos Holdings by 11.8% in the third quarter. American Century Companies Inc. now owns 684,874 shares of the specialty chemicals company’s stock valued at $33,689,000 after buying an additional 72,439 shares in the last quarter. Stevens Capital Management LP increased its holdings in Innophos Holdings by 18.0% in the third quarter. Stevens Capital Management LP now owns 7,006 shares of the specialty chemicals company’s stock valued at $345,000 after buying an additional 1,070 shares in the last quarter. Finally, Old Mutual Global Investors UK Ltd. purchased a new position in Innophos Holdings in the third quarter valued at about $109,000. 94.48% of the stock is owned by institutional investors.

Innophos Holdings, Inc. (NASDAQ IPHS) remained flat at $$44.32 during mid-day trading on Friday. 2,323 shares of the company traded hands, compared to its average volume of 112,380. The firm has a market capitalization of $871.97, a price-to-earnings ratio of 18.15 and a beta of 0.88. Innophos Holdings, Inc. has a 1-year low of $41.66 and a 1-year high of $58.22. The company has a debt-to-equity ratio of 0.83, a current ratio of 2.86 and a quick ratio of 1.49.

Innophos Holdings (NASDAQ:IPHS) last released its quarterly earnings results on Tuesday, October 31st. The specialty chemicals company reported $0.78 EPS for the quarter, beating the consensus estimate of $0.72 by $0.06. The business had revenue of $184.00 million for the quarter, compared to analyst estimates of $179.33 million. Innophos Holdings had a net margin of 6.19% and a return on equity of 13.90%. The company’s quarterly revenue was down 1.1% on a year-over-year basis. During the same period in the prior year, the business earned $0.69 earnings per share. analysts predict that Innophos Holdings, Inc. will post 2.5 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 6th. Stockholders of record on Friday, November 17th will be given a $0.48 dividend. The ex-dividend date of this dividend is Thursday, November 16th. This represents a $1.92 annualized dividend and a dividend yield of 4.33%. Innophos Holdings’s dividend payout ratio is presently 88.48%.

TRADEMARK VIOLATION NOTICE: This article was originally reported by Daily Political and is owned by of Daily Political. If you are accessing this article on another website, it was illegally copied and republished in violation of U.S. and international copyright and trademark law. The original version of this article can be accessed at https://www.dailypolitical.com/2017/11/10/innophos-holdings-inc-iphs-shares-bought-by-ghp-investment-advisors-inc.html.

A number of research analysts have issued reports on the stock. Zacks Investment Research cut shares of Innophos Holdings from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 4th. KeyCorp reaffirmed a “hold” rating on shares of Innophos Holdings in a report on Wednesday, November 1st.

Innophos Holdings Company Profile

Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other.

Want to see what other hedge funds are holding IPHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innophos Holdings, Inc. (NASDAQ:IPHS).

Institutional Ownership by Quarter for Innophos Holdings (NASDAQ:IPHS)

Receive News & Ratings for Innophos Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.